OC-001

N/A

Report date: 2026/01/13 20:00:24

Base Information

Drug NameOC-001
Drug Alias NameOC-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonists
TargetsTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisUrinary Bladder Neoplasms +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTvm Capital Life Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOcellaris Pharma Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasm MetastasisUrinary Bladder Neoplasms +[16] 

Other Information

ATC CodeN/A
Related LinksN/A